MA16.06 Phase I/II Study of AC0010, Mutant-Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
• 作者

  Yi Long Wu; Qing Zhou; Xiaoqing Liu; Li Zhang; Jianying Zhou; Lin Wu; Tongtong An; Ying Cheng; Xin Zheng; Bei Hu; Ji Jiang; Xin Fang; Wanhong Xu; Xiao Xu;

  展开▼
• 作者单位

  Guangdong Lung Cancer Institute Guangdong General Hospital (GGH)and Guangdong Academy of Medical;

  Guangdong Lung Cancer Institute Guangdong General Hospital (GGH)and Guangdong Academy of Medical;

  Affiliated Hospital of Academy of Military Medical Science;

  Department of Respiratory Diseases Peking Union Medical College Hospital Peking Union Medical;

  Department of Respiratory Disease Thoracic Disease Center the First Affiliated Hospital College;

  Department of Thoracic Medical Oncology Peking University School of Oncology Beijing Cancer;

  Department of Thoracic Medicine the Affiliated Cancer Hospital of Xiangya School of Medicine;

  Jilin Province Cancer Hospital;

  Clinical Pharmacology Research Center Peking Union Medical College Hospital Peking Union Medical;

  Clinical Pharmacology Research Center Peking Union Medical College Hospital Peking Union Medical;

  Clinical Pharmacology Research Center Peking Union Medical College Hospital Peking Union Medical;

  Acea Pharmaceutical Research Hangzhou China and Acea Biosciences Inc. San Diego USA;

  Acea Pharmaceutical Research Hangzhou China and Acea Biosciences Inc. San Diego USA;

  Acea Pharmaceutical Research Hangzhou China and Acea Biosciences Inc. San Diego USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词